Precautions after vaccinating immunosuppressed patients with mRNA-based vaccines against SARS-CoV-2: does one size fit all?

Tau, Noam; Manuel, Oriol; Rozen-Zvi, Benaya; Shargian, Liat; Yahav, Dafna

Tau, Noam; Manuel, Oriol; Rozen-Zvi, Benaya; Shargian, Liat; Yahav, Dafna.

Tau N; Department of Diagnostic Imaging, Sheba Medical Center, Ramat Gan, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: taunoam@gmail.com.
Manuel O; Infectious Diseases Service and Transplantation Center, University Hospital and University of Lausanne, Lausanne, Switzerland.
Rozen-Zvi B; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Department of Nephrology and Hypertension, Rabin Medical Center, Petah-Tikva, Israel.
Shargian L; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel.
Yahav D; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Infectious Diseases Unit, Rabin Medical Center, Beilinson Campus, Petah-Tikva, Israel.

Clin Microbiol Infect ; 27(12): 1727-1728, 2021 12.

Article in English | MEDLINE | ID: covidwho-1351588

Subject(s)

COVID-19 Vaccines/administration & dosage; COVID-19; Immunocompromised Host; COVID-19/prevention & control; Humans; mRNA Vaccines/administration & dosage

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunocompromised Host / COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Clin Microbiol Infect Journal subject: Communicable Diseases / Microbiology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google